Skip to content

Earnings yield at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.5%+0.3pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.8%+0.3pp
Danaher logo
DanaherDHR
2.7%+0.2pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-14.9%+136pp
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-0.8%-0.4pp
TEC
Bio-TechneTECH
1.4%-0.4pp

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s earnings yield?
Cytek Biosciences, Inc. (CTKB) reported earnings yield of -13.2% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.